Laboratory Corporation Of America Holdings narrowed forth quarter of 2023 net loss per share of $-1.97 compare to net loss per share of $-13.00 recorded in the same quarter a year ago a decrease from $2.11 eps realized in III. Quarter (Sep 30 2023).
forth quarter of 2023
Earnings Per Share
Revenues
$ -1.97
$
2,293 Mill
$+11.03
$-1,381M-37.59 %
Laboratory Of America Holdings's Revenue
fell by
-37.59 % in forth quarter of 2023 (Dec 31 2023) year on year,
to $2,293 million and
declined by
-24.98 % sequentially.
Laboratory Of America Holdings's
in theforth quarter of 2023 recorded net loss of $-166.800 million, compare to net income of $76.400 million achieved in IV. Quarter a year ago.
Sequentially
company realized a net loss, compared to net income of $183.600 million in the previous quarter.
Laboratory Of America Holdings Inventories Inventories grew by 0.85 % to $475 million from IV. Quarter a year ago, sequentially inventories rose by 2.93 %.
In Dec 31 2023 company's net cash and cash equivalents decreased by $-191 million, capital expenditures fell by -143.316.68%, to $-167 millions compare to same quarter a year ago
Laboratory Corporation Of America Holdings
payed out dividend of $0.70 per share in last 52 weeks representing 15.05 % of net earning per share in trailing twelve-month period.
During the same period Laboratory Corporation Of America Holdings earned $ 4.56 cash per share, on a free-cash flow basis
97.97 % of net earning per share.